Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

• François Bertucci,
• Alexandre De Nonneville,
• Pascal Finetti,
• Emilie Mamessier

Affiliations

François Bertucci

Laboratory of Predictive Oncology Label Team “Ligue contre le cancer” Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University Inserm UMR1068 CNRS UMR725 Marseille France

Alexandre De Nonneville

Laboratory of Predictive Oncology Label Team “Ligue contre le cancer” Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University Inserm UMR1068 CNRS UMR725 Marseille France

Pascal Finetti

Laboratory of Predictive Oncology Label Team “Ligue contre le cancer” Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University Inserm UMR1068 CNRS UMR725 Marseille France

Emilie Mamessier

Laboratory of Predictive Oncology Label Team “Ligue contre le cancer” Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University Inserm UMR1068 CNRS UMR725 Marseille France